High serum levels of leucine-rich α-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancer CONCLUSIONS: This study highlights the potential of LRG-1 as an independent prognostic biomarker in patients with early … ← Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms SNUPN deficiency causes a recessive muscular dystrophy due to RNA mis-splicing and ECM dysregulation →